Comparing MitraClip and PASCAL for treating mitral regurgitation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the differences in outcomes between two transcatheter devices, MitraClip and PASCAL, used for edge-to-edge repair of the mitral valve in patients with mitral regurgitation. It aims to evaluate their effectiveness in a diverse patient population, including those with complex anatomical conditions. The study will include patients who are recommended for this procedure by a heart team and will assess the performance of both devices in a real-world clinical setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age equal or above 18 years
* Written consent
* Heart Team recommends M-TEER

Exclusion Criteria:

* Mitral Stenosis (MV mean PG \> 5 mmHg)
* Cardiogenic shock or hemodynamic instability at the time of intervention
* Active endocarditis
* Participant in another interventional cardiology study

Where it's running

• LMU Klinikum
  Munich, Bavaria, Germany Recruiting

Study contacts

• Principal investigator: Jörg Hausleiter, Prof. Dr. — LMU Klinikum
• Study coordinator: Jörg Hausleiter, Prof. Dr.
• Email: Joerg.Hausleiter@med.uni-muenchen.de
• Phone: +4989440072361

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Longitudinal Assessment of Cardiac MRI Microstructure in Patients and Healthy People

  This study tests advanced, non-contrast and extended clinical cardiac MRI techniques to see how heart tissue features differ between people with heart disease and healthy individuals.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07081711

• Assessing arterial stiffness and heart disease risk using a novel technology

  This study is testing a new, no-touch technology to measure how stiff your arteries are and see if it can help figure out your risk for heart disease.

  Recruiting at 3 sites HJN Sverige AB/Neko Health · Stockholm and 2 other locations · NCT06984211

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• AI-based assessment of heart function using ECG wearable monitors

  This study tests if a new AI tool using a wearable heart monitor can accurately check heart function in people with heart failure compared to traditional heart scans.

  Recruiting at 8 sites Peerbridge Health, Inc · Orange, California and 7 other locations · NCT06699056

• Left atrial shunt to help after mitral valve surgery

  This study tests whether making a small opening between the left and right atria during mitral valve repair can relieve high left atrial pressure for adults with primary mitral regurgitation.

  Recruiting Ottawa Heart Institute Research Corporation · Ottawa, Ontario · NCT06547788

• Registry for transcatheter repair of tricuspid regurgitation

  This study is collecting information on how well transcatheter repairs or replacements for the tricuspid valve work for people with tricuspid regurgitation to help improve treatment choices for them.

  Recruiting LMU Klinikum · Munich, Bavaria · NCT06307262

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.